Skip to content

What are the ingredients in Synaleve? Understanding a Potent Combination

4 min read

As a prescription medication once used for pain and anxiety, Synaleve's powerful and potentially addictive ingredients are a crucial topic for understanding its associated risks. Its formulation includes both strong analgesics and a sedative, a combination that has largely been superseded by more modern and targeted therapies.

Quick Summary

Synaleve is a combination prescription drug containing the active ingredients Paracetamol, Codeine, and Meprobamate. The synergistic effects create risks of addiction, dependence, and adverse side effects due to its controlled substances.

Key Points

  • Active Ingredients: The primary components of Synaleve are Paracetamol (Acetaminophen), Codeine Phosphate, and Meprobamate.

  • Drug Classification: Synaleve combines an over-the-counter painkiller (paracetamol), an opioid analgesic (codeine), and an anxiolytic tranquilizer (meprobamate).

  • Dependence Risk: Both Codeine and Meprobamate carry a high potential for abuse and dependence, making Synaleve a controlled substance.

  • Side Effects: The combination can cause significant side effects, including CNS depression, addiction, liver damage, and severe withdrawal symptoms if stopped abruptly.

  • Modern Use: Due to its high-risk profile and the availability of safer alternatives, Synaleve is rarely used today and has been largely replaced by more targeted treatments.

In This Article

The Core Active Ingredients

Synaleve's therapeutic and aversive effects stem from its combination of three active pharmaceutical ingredients: Paracetamol, Codeine, and Meprobamate. Each component has a distinct function, and their combined effect is what defined the drug's use profile. This mixture of a common pain reliever, an opioid, and a tranquilizer requires careful consideration due to the potential for abuse and significant side effects, particularly relating to the latter two ingredients.

Paracetamol (Acetaminophen)

Paracetamol, also known as acetaminophen, is a widely used over-the-counter pain reliever and fever reducer. In Synaleve, it serves as the non-opioid analgesic component. It is generally considered safe when taken at recommended doses but carries a significant risk of liver damage if an overdose occurs. This risk is amplified when combined with other substances that affect the central nervous system, such as alcohol, and in individuals with pre-existing liver conditions.

Codeine Phosphate

Codeine is an opioid analgesic, meaning it works on the central nervous system to relieve pain. In Synaleve, it works in tandem with paracetamol to provide stronger pain relief. However, as an opioid, codeine carries a high risk of addiction, dependence, and withdrawal symptoms with prolonged use. This is one of the primary reasons Synaleve is considered a controlled substance.

Meprobamate

Meprobamate is a tranquilizer that was historically used to treat anxiety disorders. It acts as a central nervous system depressant by binding to GABAA receptors, resulting in sedation and muscle relaxation. In Synaleve, its purpose was to address the anxiety and tension that often accompany chronic pain. However, meprobamate is a Schedule IV controlled substance due to its high potential for abuse and dependence, similar to barbiturates. Its use has declined significantly as safer and more effective anti-anxiety medications have become available.

How the Ingredients Work Together

The formulation of Synaleve is designed to provide comprehensive relief by targeting multiple aspects of pain and associated discomfort. The analgesic effects of paracetamol and codeine address the physical pain, while the sedative and muscle-relaxant properties of meprobamate help alleviate anxiety and muscle tension. This synergistic approach was intended to make the drug more effective for certain conditions, but also increases the risks of adverse interactions and sedation. The combination of CNS depressants like codeine and meprobamate can lead to profound sedation, respiratory depression, and overdose, especially when combined with other depressants like alcohol.

Inactive Ingredients (Excipients)

In addition to the active ingredients, medications contain inactive ingredients, or excipients, which help with the drug's formulation, stability, and delivery. While specific excipients can vary by manufacturer and product, a related meprobamate product's package insert mentions inactive ingredients such as colloidal silicon dioxide, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, and stearic acid. These binders and fillers are essential for creating the pill or capsule but have no therapeutic effect themselves. Allergies or sensitivities to certain excipients can sometimes occur.

Risks, Warnings, and Side Effects

Due to the inclusion of multiple powerful and habit-forming drugs, Synaleve carries significant risks that have led to its limited modern use. The side effects associated with its components include:

  • Central Nervous System (CNS) Depression: Drowsiness, dizziness, impaired coordination, slurred speech, and confusion are common side effects from both codeine and meprobamate.
  • Addiction and Dependence: The potential for both physical and psychological dependence is high with both codeine and meprobamate. Long-term use requires careful supervision.
  • Severe Withdrawal Symptoms: Abruptly stopping the medication after prolonged use can trigger serious withdrawal effects, including seizures, vomiting, tremors, and hallucinations.
  • Liver Damage: High doses or misuse of the paracetamol component can cause severe liver damage, which can be fatal.
  • Overdose Risk: Overdosing on Synaleve, especially when combined with alcohol or other depressants, can lead to life-threatening respiratory depression, coma, and death.
  • Allergic Reactions: Rash, hives, swelling, and difficulty breathing can occur, warranting immediate medical attention.

Synaleve vs. Modern Treatments: A Comparative Look

Synaleve's older formulation is contrasted with modern approaches that often use safer, more targeted agents. This table highlights some key differences:

Feature Synaleve Modern Alternatives
Active Ingredients Paracetamol, Codeine, Meprobamate NSAIDs (Ibuprofen, Naproxen), SSRIs (for anxiety), or targeted analgesics
Drug Class Opioid, Tranquilizer Non-Opioid Analgesic, Anxiolytic (often non-addictive)
Addiction Risk High Generally Lower to None
Safety Profile Poor (Sedation, Overdose Risk) Improved and more predictable, fewer severe side effects
Modern Usage Rare/Discontinued in many regions Standard of Care for pain and anxiety management
Treatment Focus Broad (Pain, Anxiety, Tension) Targeted (Specific Pain Type, Anxiety Disorder)

Conclusion: The Decline of an Older Formulation

Synaleve represents an older pharmacological approach to treating pain and anxiety with a single, powerful combination drug. However, the inclusion of codeine and, most notably, the high-risk tranquilizer meprobamate, means the medication carries a significant potential for dependence, abuse, and adverse side effects. With the development of modern medications that offer safer and more targeted treatment options, Synaleve and similar older formulations have fallen out of favor. For this reason, it is crucial to consult a healthcare provider for a thorough evaluation and discussion of all potential risks and benefits before considering any such medication.

For more detailed information on meprobamate and its safety profile, refer to the drug information page from Drugs.com: Drugs.com: Meprobamate Uses, Side Effects & Warnings.


Disclaimer: This information is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before starting or stopping any medication.

Frequently Asked Questions

The three main active ingredients in Synaleve are Paracetamol (Acetaminophen), Codeine Phosphate, and Meprobamate.

Synaleve is not commonly used anymore because its ingredients, particularly Codeine and Meprobamate, carry a high risk of addiction, dependence, and serious side effects. Safer and more effective alternatives exist for pain and anxiety management.

Yes, Synaleve is considered addictive. Its formulation includes both Codeine, an opioid, and Meprobamate, a tranquilizer with known dependence potential, making it a controlled substance.

Side effects can include central nervous system depression (drowsiness, dizziness), addiction, liver damage from paracetamol overdose, and severe withdrawal symptoms if discontinued abruptly.

Combining Synaleve with alcohol is extremely dangerous, as both are central nervous system depressants. This can lead to increased sedation, respiratory depression, coma, and even death.

Meprobamate works as a tranquilizer by affecting GABAA receptors in the central nervous system, which helps calm the nervous system and provides sedative and muscle-relaxant effects.

Synaleve's availability is limited, often restricted to specific regions like South Africa, and requires a prescription due to its status as a controlled substance.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.